LRP2 and DOCK8 Are Potential Antigens for mRNA Vaccine Development in Immunologically ‘Cold’ KIRC Tumours

The administration of mRNA-based tumour vaccines is considered a promising strategy in tumour immunotherapy, although its application against kidney renal clear cell carcinoma (KIRC) is still at its infancy stage. The purpose of this study was to identify potential antigens and to further select sui...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shichao, Xia, Kaide, Chang, Yue, Wei, Yimei, Xiong, Yu, Tang, Fuzhou, Peng, Jian, Ouyang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966310/
https://www.ncbi.nlm.nih.gov/pubmed/36851274
http://dx.doi.org/10.3390/vaccines11020396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966310/
https://www.ncbi.nlm.nih.gov/pubmed/36851274
http://dx.doi.org/10.3390/vaccines11020396

Ejemplares similares